Kamada Ltd. Ordinary Shares (KMDA)

FairStock Score: 47/100 — MIXED

Key Financials

Strengths

• Generates $8 million in annual free cash flow (1.6% yield on market cap)
• Conservative balance sheet with debt-to-equity of just 0.04, providing financial flexibility
• Attractive 3.0% dividend yield providing steady income returns

AI Analysis

Kamada Ltd. Ordinary Shares is a micro-cap healthcare company valued at $482 million. The business generates $180 million in annual revenue with a 6.1% net margin and $8 million in free cash flow. From a quality standpoint, Kamada shows healthy Altman Z-Score of 3.2 and modest 8% ROE. On valuation, the stock is reasonably priced at 23.6x earnings, with trades above its Graham Number with a negative 38% margin. Growth dynamics show revenue growing at 14.5% and profit growth of -6.5%. The 3.0% dividend yield adds an income component for patient holders. Our composite FairStock Score of 47/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $8 million in annual free cash flow (1.6% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer